{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T19:57:44Z","timestamp":1773259064789,"version":"3.50.1"},"reference-count":47,"publisher":"Impact Journals, LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Aging"],"DOI":"10.18632\/aging.205616","type":"journal-article","created":{"date-parts":[[2024,2,29]],"date-time":"2024-02-29T16:29:06Z","timestamp":1709224146000},"source":"Crossref","is-referenced-by-count":4,"title":["GBA3 promotes fatty acid oxidation and alleviates non-alcoholic fatty liver by increasing CPT2 transcription"],"prefix":"10.18632","author":[{"given":"Juyi","family":"Li","sequence":"first","affiliation":[{"name":"Department of Endocrinology, Geriatrics Center, The First Affiliated Hospital of Anhui University of Chinese Medicine, Hefei 230001, Anhui, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yingqun","family":"Ni","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, The First Affiliated Hospital of Anhui University of Chinese Medicine, Hefei 230001, Anhui, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuanyuan","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Geriatrics Center, The First Affiliated Hospital of Anhui University of Chinese Medicine, Hefei 230001, Anhui, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huaizhen","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Geriatrics Center, The First Affiliated Hospital of Anhui University of Chinese Medicine, Hefei 230001, Anhui, China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"7892","published-online":{"date-parts":[[2024,2,29]]},"reference":[{"key":"1","doi-asserted-by":"publisher","first-page":"101122","DOI":"10.1016\/j.molmet.2020.101122","article-title":"Nonalcoholic fatty liver disease (NAFLD) from pathogenesis to treatment concepts in humans.","volume":"5","author":"Roden","year":"2021","journal-title":"Mol Metab"},{"key":"2","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1016\/j.cgh.2011.03.020","article-title":"Changes in the prevalence of the most common causes of chronic liver diseases in the United States from 1988 to 2008.","volume":"9","author":"Srishord","year":"2011","journal-title":"Clin Gastroenterol Hepatol"},{"key":"3","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1002\/hep.28431","article-title":"Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes.","volume":"6","author":"Wymer","year":"2016","journal-title":"Hepatology"},{"key":"4","doi-asserted-by":"publisher","first-page":"774","DOI":"10.3390\/ijms17050774","article-title":"The Natural Course of Non-Alcoholic Fatty Liver Disease.","volume":"1","author":"Adams","year":"2016","journal-title":"Int J Mol Sci"},{"key":"5","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1016\/j.jhep.2020.03.039","article-title":"A new definition for metabolic dysfunction-associated fatty liver disease: An international expert consensus statement.","volume":"7","author":"Valenti","year":"2020","journal-title":"J Hepatol"},{"key":"6","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1016\/j.tem.2017.11.009","article-title":"Palmitic and Oleic Acid: The Yin and Yang of Fatty Acids in Type 2 Diabetes Mellitus.","volume":"2","author":"V\u00e1zquez-Carrera","year":"2018","journal-title":"Trends Endocrinol Metab"},{"key":"7","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1038\/s41575-018-0065-y","article-title":"Apoptosis and necroptosis in the liver: a matter of life and death.","volume":"1","author":"Luedde","year":"2018","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"8","doi-asserted-by":"publisher","first-page":"1418","DOI":"10.1038\/s41418-020-00668-w","article-title":"RIP1 kinase activity promotes steatohepatitis through mediating cell death and inflammation in macrophages.","volume":"2","author":"Ding","year":"2021","journal-title":"Cell Death Differ"},{"key":"9","doi-asserted-by":"publisher","first-page":"11565","DOI":"10.1038\/s41598-020-68106-y","article-title":"GBA3: a polymorphic pseudogene in humans that experienced repeated gene loss during mammalian evolution.","volume":"1","author":"Prata","year":"2020","journal-title":"Sci Rep"},{"key":"10","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1046\/j.0014-2956.2001.02641.x","article-title":"Functional expression of human liver cytosolic beta-glucosidase in Pichia pastoris. Insights into its role in the metabolism of dietary glucosides.","volume":"26","author":"Juge","year":"2002","journal-title":"Eur J Biochem"},{"key":"11","first-page":"14027","article-title":"Exolytic hydrolysis of toxic plant glucosides by guinea pig liver cytosolic beta-glucosidase.","volume":"26","author":"Glew","year":"1992","journal-title":"J Biol Chem"},{"key":"12","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1042\/0264-6021:3560907","article-title":"Cloning and characterization of human liver cytosolic beta-glycosidase.","volume":"35","author":"Haisma","year":"2001","journal-title":"Biochem J"},{"key":"13","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.4149\/neo_2020_190928N980","article-title":"Decreased expression of GBA3 correlates with a poor prognosis in hepatocellular carcinoma patients.","volume":"6","author":"Mou","year":"2020","journal-title":"Neoplasma"},{"key":"14","doi-asserted-by":"publisher","first-page":"e135197","DOI":"10.1172\/JCI135197","article-title":"TREM2 sustains macrophage-hepatocyte metabolic coordination in nonalcoholic fatty liver disease and sepsis.","volume":"13","author":"Wang","year":"2021","journal-title":"J Clin Invest"},{"key":"15","doi-asserted-by":"publisher","first-page":"e47","DOI":"10.1093\/nar\/gkv007","article-title":"limma powers differential expression analyses for RNA-sequencing and microarray studies.","volume":"4","author":"Smyth","year":"2015","journal-title":"Nucleic Acids Res"},{"key":"16","doi-asserted-by":"publisher","DOI":"10.1002\/cpbi.5","article-title":"The GeneCards Suite: From Gene Data Mining to Disease Genome Sequence Analyses.","volume":"5","author":"Warshawsky","year":"2016","journal-title":"Curr Protoc Bioinformatics"},{"key":"17","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/1471-2105-14-7","article-title":"GSVA: gene set variation analysis for microarray and RNA-seq data.","volume":"1","author":"Guinney","year":"2013","journal-title":"BMC Bioinformatics"},{"key":"18","doi-asserted-by":"publisher","first-page":"D498","DOI":"10.1093\/nar\/gkz1031","article-title":"The reactome pathway knowledgebase.","volume":"4","author":"Milacic","year":"2020","journal-title":"Nucleic Acids Res"},{"key":"19","doi-asserted-by":"publisher","first-page":"1881","DOI":"10.1136\/gutjnl-2017-314307","article-title":"Suppressed hepatic bile acid signalling despite elevated production of primary and secondary bile acids in NAFLD.","volume":"6","author":"Zhu","year":"2018","journal-title":"Gut"},{"key":"20","doi-asserted-by":"publisher","first-page":"e0234493","DOI":"10.1371\/journal.pone.0234493","article-title":"Pharmacological inhibition of carnitine palmitoyl transferase 1 inhibits and reverses experimental autoimmune encephalitis in rodents.","volume":"1","author":"Nieland","year":"2020","journal-title":"PLoS One"},{"key":"21","doi-asserted-by":"publisher","first-page":"2609","DOI":"10.2147\/IJGM.S413545","article-title":"Identification and Validation of Hub Immune-Related Genes in Non-Alcoholic Fatty Liver Disease.","volume":"1","author":"Zhang","year":"2023","journal-title":"Int J Gen Med"},{"key":"22","first-page":"2984","article-title":"Development and validation of a N6 methylation regulator-related gene signature for prognostic and immune response prediction in non-small cell lung cancer.","volume":"1","author":"Cao","year":"2023","journal-title":"Am J Cancer Res"},{"key":"23","doi-asserted-by":"publisher","first-page":"e1369","DOI":"10.1002\/ctm2.1369","article-title":"Arginine methylation of PPP1CA by CARM1 regulates glucose metabolism and affects osteogenic differentiation and osteoclastic differentiation.","volume":"1","author":"Chen","year":"2023","journal-title":"Clin Transl Med"},{"key":"24","doi-asserted-by":"publisher","first-page":"3444","DOI":"10.1038\/s41467-021-23833-2","article-title":"PRMT5-mediated arginine methylation activates AKT kinase to govern tumorigenesis.","volume":"1","author":"Gan","year":"2021","journal-title":"Nat Commun"},{"key":"25","doi-asserted-by":"publisher","first-page":"7130","DOI":"10.1038\/s41467-021-27460-9","article-title":"Free fatty-acid transport via CD36 drives \u03b2-oxidation-mediated hematopoietic stem cell response to infection.","volume":"1","author":"Rushworth","year":"2021","journal-title":"Nat Commun"},{"key":"26","doi-asserted-by":"publisher","first-page":"e1912","DOI":"10.21769\/BioProtoc.1912","article-title":"BODIPY 493\/503 Staining of Neutral Lipid Droplets for Microscopy and Quantification by Flow Cytometry.","volume":"6","author":"Simon","year":"2016","journal-title":"Bio Protoc"},{"key":"27","doi-asserted-by":"publisher","first-page":"5257","DOI":"10.2147\/IJN.S112030","article-title":"Amorphous silica nanoparticles trigger vascular endothelial cell injury through apoptosis and autophagy via reactive oxygen species-mediated MAPK\/Bcl-2 and PI3K\/Akt\/mTOR signaling.","volume":"1","author":"Sun","year":"2016","journal-title":"Int J Nanomedicine"},{"key":"28","doi-asserted-by":"publisher","first-page":"4099","DOI":"10.1016\/j.molcel.2022.09.018","article-title":"Cytoplasmic SIRT6-mediated ACSL5 deacetylation impedes nonalcoholic fatty liver disease by facilitating hepatic fatty acid oxidation.","volume":"8","author":"Liu","year":"2022","journal-title":"Mol Cell"},{"key":"29","first-page":"13004","article-title":"Purification and characterization of a cytosolic broad specificity beta-glucosidase from human liver.","volume":"25","author":"Labow","year":"1981","journal-title":"J Biol Chem"},{"key":"30","doi-asserted-by":"publisher","first-page":"2661","DOI":"10.3748\/wjg.v24.i25.2661","article-title":"Apoptosis and non-alcoholic fatty liver diseases.","volume":"2","author":"Ogawa","year":"2018","journal-title":"World J Gastroenterol"},{"key":"31","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1038\/nrm.2016.149","article-title":"Necroptosis in development, inflammation and disease.","volume":"1","author":"Green","year":"2017","journal-title":"Nat Rev Mol Cell Biol"},{"key":"32","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/j.cell.2011.11.031","article-title":"Mixed lineage kinase domain-like protein mediates necrosis signaling downstream of RIP3 kinase.","volume":"14","author":"Wang","year":"2012","journal-title":"Cell"},{"key":"33","doi-asserted-by":"publisher","first-page":"3214","DOI":"10.1016\/j.cell.2022.06.038","article-title":"Mitochondrial ROS promotes susceptibility to infection via gasdermin D-mediated necroptosis.","volume":"18","author":"Li","year":"2022","journal-title":"Cell"},{"key":"34","doi-asserted-by":"publisher","first-page":"101589","DOI":"10.1016\/j.redox.2020.101589","article-title":"FoxM1-dependent and fatty acid oxidation-mediated ROS modulation is a cell-intrinsic drug resistance mechanism in cancer stem-like cells.","volume":"3","author":"Cheong","year":"2020","journal-title":"Redox Biol"},{"key":"35","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1007\/s00018-018-2947-0","article-title":"Molecular pathways of nonalcoholic fatty liver disease development and progression.","volume":"7","author":"Roma","year":"2019","journal-title":"Cell Mol Life Sci"},{"key":"36","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1007\/s42764-022-00070-5","article-title":"Long non-coding RNAs regulate fatty acid and cholesterol metabolism.","volume":"3","author":"Lei","year":"2022","journal-title":"Genome Instability and Disease"},{"key":"37","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1016\/j.tem.2016.11.006","article-title":"Mitochondrial Adaptation in Nonalcoholic Fatty Liver Disease: Novel Mechanisms and Treatment Strategies.","volume":"2","author":"Cusi","year":"2017","journal-title":"Trends Endocrinol Metab"},{"key":"38","doi-asserted-by":"publisher","first-page":"1497","DOI":"10.1002\/hep.26226","article-title":"Mitochondrial adaptations and dysfunctions in nonalcoholic fatty liver disease.","volume":"5","author":"Fromenty","year":"2013","journal-title":"Hepatology"},{"key":"39","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/j.jhep.2016.08.024","article-title":"Inhibiting poly ADP-ribosylation increases fatty acid oxidation and protects against fatty liver disease.","volume":"6","author":"Kim","year":"2017","journal-title":"J Hepatol"},{"key":"40","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1007\/s11427-019-9591-5","article-title":"Oxidative stress, nutritional antioxidants and beyond.","volume":"6","author":"Yin","year":"2020","journal-title":"Sci China Life Sci"},{"key":"41","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1038\/s41575-019-0145-7","article-title":"From NASH to HCC: current concepts and future challenges.","volume":"1","author":"Heikenwalder","year":"2019","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"42","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1016\/j.cmet.2015.04.004","article-title":"Adaptation of hepatic mitochondrial function in humans with non-alcoholic fatty liver is lost in steatohepatitis.","volume":"2","author":"Roden","year":"2015","journal-title":"Cell Metab"},{"key":"43","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1042\/CS20140732","article-title":"Necroptosis is a key pathogenic event in human and experimental murine models of non-alcoholic steatohepatitis.","volume":"12","author":"Rodrigues","year":"2015","journal-title":"Clin Sci (Lond)"},{"key":"44","doi-asserted-by":"publisher","first-page":"2063","DOI":"10.1056\/NEJMra1503519","article-title":"Cause, Pathogenesis, and Treatment of Nonalcoholic Steatohepatitis.","volume":"37","author":"Day","year":"2017","journal-title":"N Engl J Med"},{"key":"45","doi-asserted-by":"publisher","first-page":"1518","DOI":"10.1002\/hep.28676","article-title":"Receptor interacting protein 3 protects mice from high-fat diet-induced liver injury.","volume":"6","author":"Nagy","year":"2016","journal-title":"Hepatology"},{"key":"46","doi-asserted-by":"publisher","first-page":"1062","DOI":"10.15252\/emmm.201403856","article-title":"A positive feedback loop between RIP3 and JNK controls non-alcoholic steatohepatitis.","volume":"6","author":"Luedde","year":"2014","journal-title":"EMBO Mol Med"},{"key":"47","doi-asserted-by":"publisher","first-page":"1499","DOI":"10.3390\/biom5031499","article-title":"Co-Expression of NEU2 and GBA3 Causes a Drastic Reduction in Cytosolic Sialyl Free N-glycans in Human MKN45 Stomach Cancer Cells-Evidence for the Physical Interaction of NEU2 and GBA3.","volume":"5","author":"Suzuki","year":"2015","journal-title":"Biomolecules"}],"container-title":["Aging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.aging-us.com\/lookup\/doi\/10.18632\/aging.205616","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,29]],"date-time":"2024-02-29T16:29:10Z","timestamp":1709224150000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.aging-us.com\/lookup\/doi\/10.18632\/aging.205616"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2,29]]},"references-count":47,"alternative-id":["205616"],"URL":"https:\/\/doi.org\/10.18632\/aging.205616","relation":{},"ISSN":["1945-4589"],"issn-type":[{"value":"1945-4589","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,2,29]]}}}